PERJETA® (pertuzumab) - Cancer Therapy Advisor

PERJETA® (pertuzumab)

Slideshow

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

This slideshow reviews drug information for PERJETA® (pertuzumab), indicated for neoadjuvant treatment of breast cancer.

Table of Contents

Slide 3: Indication, Dosage, and Administration
Slide 9: Use in Specific Populations
Slide 11: Clinical Pharmacology
Slide 14: Warnings and Precautions
Slide 17: Clinical Safety and Efficacy
Slide 25: Drug Storage and Supply

Next hm-slideshow in Slides